Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 4:00 PM View:  | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 01-Mar-24 | Private Sale (Planned) | 2,500 | $34.00 | $85,000.00 | (18%) 14.0K to 11.5K | |
| 21-Feb-24 4:04 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 1,509 | $37.21 | $56,149.90 | (< 1%) 1.23M to 1.23M | |
| 21-Feb-24 4:03 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 47,922 | $37.21 | $1,783,180.00 | (< 1%) 6.92M to 6.88M | |
| 21-Feb-24 4:04 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Payment of Exercise | 18,919 | $37.21 | $703,976.00 | (23%) 81.83K to 62.91K | |
| 21-Feb-24 4:04 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 3,760 | -- | -- | < 1% 1.23M to 1.23M | |
| 21-Feb-24 4:03 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 21-Feb-24 4:04 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Feb-24 | Option Exercise | 44,996 | -- | -- | 122% 36.83K to 81.83K | |
| 20-Feb-24 4:03 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Feb-24 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 56% 5.2K to 8.11K | |
| 20-Feb-24 4:03 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Feb-24 | Planned Option Sale | 2,915 | $37.75 | $110,041.00 | (36%) 8.11K to 5.2K | |
| 18-Jan-24 4:10 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 16-Jan-24 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 165% 1.76K to 4.68K | |
| 18-Jan-24 4:10 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 16-Jan-24 | Planned Option Sale | 2,915 | $37.97 | $110,683.00 | (62%) 4.68K to 1.76K | |
| 28-Dec-23 4:00 PM View: | McCormick Frank Director | Bridgebio Pharma, Inc. (BBIO) | 26-Dec-23 | Private Sale (Planned) | 100,000 | $42.06 | $4,206,000.00 | (8%) 1.2M to 1.1M | |
| 20-Dec-23 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 18-Dec-23 | Private Sale (Planned) | 2,000 | $40.00 | $80,000.00 | (12%) 16.0K to 14.0K | |
| 19-Dec-23 4:00 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-23 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 165% 1.76K to 4.68K | |
| 19-Dec-23 4:00 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Dec-23 | Planned Option Sale | 2,915 | $36.12 | $105,290.00 | (62%) 4.68K to 1.76K | |
| 05-Dec-23 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 01-Dec-23 | Private Sale (Planned) | 2,500 | $29.40 | $73,500.00 | (14%) 18.5K to 16.0K | |
| 20-Nov-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-23 | Planned Option Sale | 51,552 | $29.10 | $1,500,040.00 | (< 1%) 6.87M to 6.82M | |
| 20-Nov-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 17-Nov-23 | Planned Option Sale | 22,685 | $29.10 | $660,059.00 | (38%) 59.4K to 36.71K | |
| 20-Nov-23 4:00 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 3,760 | -- | -- | < 1% 1.22M to 1.23M | |
| 20-Nov-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 50,697 | $28.86 | $1,463,120.00 | (< 1%) 6.92M to 6.87M | |
| 20-Nov-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 22,311 | $28.86 | $643,896.00 | (27%) 81.71K to 59.4K | |
| 20-Nov-23 4:00 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Payment of Exercise | 1,301 | $28.86 | $37,546.90 | (< 1%) 1.23M to 1.23M | |
| 20-Nov-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 20-Nov-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Nov-23 | Option Exercise | 44,996 | -- | -- | 123% 36.71K to 81.71K | |
| 17-Nov-23 4:09 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Nov-23 | Planned Option Sale | 2,915 | $30.00 | $87,450.00 | (62%) 4.68K to 1.76K | |
| 17-Nov-23 4:09 PM View: | Valantine Hannah Director | Bridgebio Pharma, Inc. (BBIO) | 15-Nov-23 | Option Exercise | 2,915 | $8.45 | $24,631.80 | 165% 1.76K to 4.68K | |
| 07-Sep-23 4:00 PM View: | Scott Randal W Director | Bridgebio Pharma, Inc. (BBIO) | 05-Sep-23 | Private Sale (Planned) | 2,500 | $30.00 | $75,000.00 | (12%) 21.0K to 18.5K | |
| 18-Aug-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 17-Aug-23 | Planned Option Sale | 51,552 | $28.59 | $1,473,780.00 | (< 1%) 6.87M to 6.82M | |
| 18-Aug-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 17-Aug-23 | Planned Option Sale | 22,683 | $28.59 | $648,455.00 | (38%) 59.39K to 36.71K | |
| 18-Aug-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Option Exercise | 102,250 | -- | -- | 1% 6.82M to 6.92M | |
| 18-Aug-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Option Exercise | 44,994 | -- | -- | 123% 36.71K to 81.7K | |
| 18-Aug-23 4:00 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Option Exercise | 3,760 | -- | -- | < 1% 1.22M to 1.23M | |
| 18-Aug-23 4:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Payment of Exercise | 50,698 | $29.80 | $1,510,800.00 | (< 1%) 6.92M to 6.87M | |
| 18-Aug-23 4:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Payment of Exercise | 22,311 | $29.80 | $664,868.00 | (27%) 81.7K to 59.39K | |
| 18-Aug-23 4:00 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-Aug-23 | Payment of Exercise | 1,301 | $29.80 | $38,769.80 | (< 1%) 1.23M to 1.22M | |
| 19-Jul-23 9:33 PM View: | Viking Global Investors Lp 10% Owner | Bridgebio Pharma, Inc. (BBIO) | 18-Jul-23 | Private Sale | 1,500,000 | $35.00 | $52,500,000.00 | (6%) 26.62M to 25.12M | |
| 18-May-23 4:07 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 17-May-23 | Planned Option Sale | 51,552 | $14.01 | $722,218.00 | (< 1%) 6.87M to 6.82M | |
| 18-May-23 4:02 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 17-May-23 | Planned Option Sale | 24,424 | $14.01 | $342,168.00 | (40%) 60.83K to 36.41K | |
| 18-May-23 4:05 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Option Exercise | 3,759 | -- | -- | < 1% 1.22M to 1.22M | |
| 18-May-23 4:07 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Payment of Exercise | 50,697 | $14.09 | $714,321.00 | (< 1%) 6.92M to 6.87M | |
| 18-May-23 4:02 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Payment of Exercise | 20,572 | $14.09 | $289,859.00 | (25%) 81.4K to 60.83K | |
| 18-May-23 4:05 PM View: | Homcy Charles J Director | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Payment of Exercise | 1,300 | $14.09 | $18,317.00 | (< 1%) 1.22M to 1.22M | |
| 18-May-23 4:07 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Option Exercise | 102,249 | -- | -- | 1% 6.82M to 6.92M | |
| 18-May-23 4:02 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 16-May-23 | Option Exercise | 44,996 | -- | -- | 124% 36.41K to 81.4K | |
| 05-May-23 4:03 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 03-May-23 | Market Sale (Planned) | 120,000 | $14.18 | $1,701,740.00 | (2%) 6.94M to 6.82M | (< 1%) |
| 05-May-23 4:01 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 03-May-23 | Market Sale (Planned) | 64,929 | $14.18 | $920,693.00 | (64%) 101.34K to 36.41K | (< 1%) |
| 07-Apr-23 4:39 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 05-Apr-23 | Private Sale (Planned) | 120,000 | $15.46 | $1,855,660.00 | (2%) 7.06M to 6.94M | |
| 07-Apr-23 4:42 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 05-Apr-23 | Private Sale (Planned) | 55,500 | $15.45 | $857,697.00 | (35%) 156.84K to 101.34K | |
| 03-Mar-23 10:00 PM View: | Kumar Neil CEO and President Director | Bridgebio Pharma, Inc. (BBIO) | 03-Mar-23 | Sale (Planned) | 120,000 | $10.96 | $1,315,220.00 | (2%) 7.18M to 7.06M | |
| 03-Mar-23 10:00 PM View: | Stephenson Brian C Secretary, Treasurer & CFO | Bridgebio Pharma, Inc. (BBIO) | 03-Mar-23 | Sale (Planned) | 62,692 | $10.96 | $687,148.00 | (29%) 219.53K to 156.84K |
